Targeted nanoparticles boost platinum-based anticancer therapy (News-Medical-Net)
A research team from the Massachusetts Institute of Technology (MIT)-Harvard Center for Nanotechnology Excellence has custom-designed nanoparticles that can deliver the anticancer drug cisplatin specifically to prostate cancer cells.
(get the story…)